$1.32
Pacific Biosciences of California is a medical devices business based in the US. Pacific Biosciences of California shares (PACB) are listed on the NASDAQ and all prices are listed in US Dollars. Pacific Biosciences of California employs 796 staff and has a trailing 12-month revenue of around $188.9 million.
Our top picks for where to buy Pacific Biosciences of California stock
How to buy Pacific Biosciences of California stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PACB. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Pacific Biosciences of California stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Pacific Biosciences of California stock price (NASDAQ: PACB)
Use our graph to track the performance of PACB stocks over time.Pacific Biosciences of California shares at a glance
Latest market close | $1.34 |
---|---|
52-week range | $1.16 - $11.96 |
50-day moving average | $1.59 |
200-day moving average | $4.20 |
Wall St. target price | $2.83 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.51 |
Is it a good time to buy Pacific Biosciences of California stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Pacific Biosciences of California price performance over time
Historical closes compared with the close of $1.34 from 2024-09-03
1 week (2024-08-29) | -1.47% |
---|---|
1 month (2024-08-05) | -13.27% |
3 months (2024-06-05) | -34.31% |
6 months (2024-03-05) | -69.20% |
1 year (2023-09-05) | -87.96% |
---|---|
2 years (2022-09-01) | -77.25% |
3 years (2021-09-03) | 31.23 |
5 years (2019-09-05) | 5.6 |
Pacific Biosciences of California financials
Revenue TTM | $188.9 million |
---|---|
Gross profit TTM | $53.5 million |
Return on assets TTM | -11.24% |
Return on equity TTM | -70.57% |
Profit margin | -211.99% |
Book value | $1.81 |
Market Capitalization | $373.4 million |
TTM: trailing 12 months
Pacific Biosciences of California share dividends
We're not expecting Pacific Biosciences of California to pay a dividend over the next 12 months.
Pacific Biosciences of California share price volatility
Over the last 12 months, Pacific Biosciences of California's shares have ranged in value from as little as $1.16 up to $11.96. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pacific Biosciences of California's is 2.034. This would suggest that Pacific Biosciences of California's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Pacific Biosciences of California overview
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America.
Frequently asked questions
What percentage of Pacific Biosciences of California is owned by insiders or institutions?Currently 1.868% of Pacific Biosciences of California shares are held by insiders and 85.945% by institutions. How many people work for Pacific Biosciences of California?
Latest data suggests 796 work at Pacific Biosciences of California. When does the fiscal year end for Pacific Biosciences of California?
Pacific Biosciences of California's fiscal year ends in December. Where is Pacific Biosciences of California based?
Pacific Biosciences of California's address is: 1305 O?Brien Drive, Menlo Park, CA, United States, 94025 What is Pacific Biosciences of California's ISIN number?
Pacific Biosciences of California's international securities identification number is: US69404D1081 What is Pacific Biosciences of California's CUSIP number?
Pacific Biosciences of California's Committee on Uniform Securities Identification Procedures number is: 69404D108
More guides on Finder
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
6 stocks like Nvidia you need to consider
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
Public vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Streitwise review
An online REIT with low fees, consistent dividends and a stable portfolio, but a brief track record.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question